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ABSTRACT
Pterygium are known to cause reduction in oculovisual function. However, the effects are varying due to its various 
morphological factors, thus, the impact on patient are difficult to predict which indirectly not all pterygium need to be 
excised. To describe the effects of different types of pterygium on changes in oculovisual function. Ninety-three (93) 
primary pterygium eyes from 93 patients were recruited in this study. Diagnosis and classification of primary pterygium 
were done by a consultant ophthalmologist (KMK). Standard optometric examinations were performed in all participants. 
Best-corrected visual acuity (BCVA) and contrast sensitivity (CS) was subjectively measured using computerised M&S 
Technologies Smart System II, performed by a single operator on the same visit. Pterygium excision was done based on 
a standardised method performed by a single surgeon (KMK). At third month post-surgical, repeated measurements of 
BCVA and CS were performed. Difference between pre and post-surgical was taken as magnitude changes for each 
pterygium type. Paired T-test and ANOVA were employed to evaluate the difference between pre- and post-surgical and 
pterygium types for both BCVA and CS parameters. Overall mean (n = 93) of BCVA and CS were found significantly 
associated with advance pterygium (P < 0.001). Paired T-test and ANOVA results showed a significant difference in 
BCVA and CS values between pterygium groups in pre- and post-surgical sessions and between pterygium types (both P 
< 0.001). Reduction of oculovisual function in pterygium patient is expected in advance pterygium. Management of 
pterygium should be coherent with pterygium types. 
Keywords: Best-corrected visual acuity (BCVA); contrast sensitivity; morphology; primary pterygium; pterygium 
excision 
ABSTRAK
Untuk mengkaji jenis pterigium yang mampu mengubah fungsi okulovisual. Sebanyak 93 mata daripada 93 pesakit 
pterigium primer telah direkrut untuk kajian ini. Diagnosis dan pengelasan pterigium primer dilakukan oleh pakar 
perunding oftalmologi (KMK). Semua peserta kajian telah menjalani pemeriksaan optometri piawai. Ketajaman visual 
yang diperbetulkan terbaik (BCVA) dan sensitiviti kontras (CS) diukur pada sesi yang sama untuk setiap sesi oleh 
seorang operator (MRH) secara subjektif menggunakan perisian M&S Technologies Smart System II. Pembedahan 
pterigium dilakukan oleh seorang pakar bedah (KMK) menggunakan kaedah piawai. Setelah 3 bulan pos-pembedahan, 
pengukuran BCVA dan CS dilakukan semula. Perubahan untuk setiap jenis pterigium ditakrifkan sebagai perbezaan 
magnitud antara pra dan pos-pembedahan. Ujian T-berpasangan dan ANOVA digunakan untuk menganalisis perbezaan 
antara pra dan pos-pembedahan untuk BCVA dan CS. Min keseluruhan untuk BCVA dan CS (n = 93) berkolerasi secara 
signifikan dengan lanjutan pterigium (P < 0.001). Ujian T-berpasangan dan ANOVA menunjukkan perubahan signifikan 
pada nilai BCVS dan CS antara jenis pterigium ketika pra dan pos-pembedahan dan antara jenis pterigium (kedua-dua 
P < 0.001). Untuk pesakit pterigium, pengurangan fungsi okulovisual dijangkakan berlaku pada peringkat lanjutan 
pterigium. Pengurusan pterigium seharusnya mengambil kira jenis pterigium.
Kata kunci: Kelengkungan kornea; ketajaman visual yang diperbetulkan terbaik (BCVA); morfologi; pterigium; 
sensitiviti kontras
INTRODUCTION
Pterygium is an abnormal benign, elevated, superficial, 
wedge-shaped fibrovascular proliferative lesion of the 
bulbar conjunctiva which extends on the corneal surface 
(Errais et al. 2008; Hilmi et al. 2018a; Manzar & Mahar 
2013). A pterygium occurs more commonly in people who 
have had chronic ultraviolet (UV) ray exposures (Chui et 
al. 2011; Liu et al. 2013; Maharjan et al. 2014; Marmamula 
et al. 2013) and those who live in hot, dry windy or dusty 
environment (Pan et al. 2018). It is a fact that pterygium 
is an essential factor which contributes to induced irregular 
corneal astigmatism as pterygium invades into the cornea, 
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it may cause visual disturbance due to abnormal corneal 
curvature (Zare et al. 2010). However, it is worth to note 
that clinically not the all large size of pterygium induced 
significant astigmatism as small pterygium size could give 
similar effects. Hence, degrees of severity in visual 
impairment were also tricky to predict as the size and width 
does not necessarily correlate with each other.  This could 
happen due to its morphology (fleshiness) which could 
induce an external force on the corneal curvature. 
Several clinical gradings have been proposed in 
evaluating pterygium. Pterygium can be assessed based 
on several methods such as via its fleshiness appearance 
(Che Azemin et al. 2016; Mohd Radzi et al. 2017; Tan et 
al. 1997), extension or length (Gumus et al. 2011; Han et 
al. 2016; Lawan et al. 2018; Lin & Stern 1998; Mohammad-
Salih & Sharif 2008; Nejima et al. 2015; Tan et al. 1997), 
its size (Altan-Yaycioglu et al. 2013; Farhood & Kareem 
2012; Gumus et al. 2012; Hilmi et al. 2018b; Kheirkhah 
et al. 2012; Ozgurhan et al. 2015; Vives et al. 2013) and 
based on its encroachment relative to the corneal size 
(Gumus et al. 2011; Mohammad-Salih & Sharif 2008; Zare 
et al. 2010). In 1997, Tan et al. proposed a classification 
of pterygium based on its clinical appearance (Figure 1). 
This classification is based on three (3) types or grades 
known as type I - atrophy, type II - intermediate and type 
III - fleshy. This classification is based on loss of 
translucency of pterygium tissue which relates to increased 
fleshiness that could signify the abnormal fibrovascular 
growth of pterygium. 
Visual impairment due to changes on the ocular 
surface is commonly measured using best-corrected visual 
acuity (BCVA) and contrast sensitivity function (CS). BCVA 
is defined as a measurement of visual function which 
describes the sensitivity of optical, retinal and neural 
functions of the eye (Thurman et al. 2016). Hence, BCVA 
represents the clarity and sharpness of the central vision. 
However, previous works (Altan-Yaycioglu et al. 2013; 
Farhood & Kareem 2012; Gumus et al. 2012, 2011; Han 
et al. 2016; Hilmi et al. 2018c; Kheirkhah et al. 2012; 
Lawan et al. 2018; Lin & Stern 1998; Mohammad-Salih 
& Sharif 2008; Nejima et al. 2015; Ozgurhan et al. 2015; 
Vives et al. 2013) had proved that the progression of 
pterygium would induce corneal astigmatism based on 
measurement of anterior corneal curvature.  
In contrast, CS is defined as a measurement of visual 
function specifically on variation in luminance, used to 
distinguish between finer and finer increments of luminance 
from the background (Pelli & Bex 2013). Although both 
CS and BCVA measures visual functions, CS differs from 
BCVA as it combines size and contrast in its evaluation, 
while BCVA focused on letter size. Previous studies (Hilmi 
et al. 2018b; Malik et al. 2014; Oh & Wee 2010) had 
commented that relying solely on BCVA in measuring 
visual performance is inadequate; hence CS need to be 
included in the assessment. To the best of our knowledge, 
lack of evidence found that address the effects of both 
BCVA and CS in different types of primary pterygium. This 
study would like to address the clinical importance of 
reduction in both BCVA and CS based on its pterygium 
types as potential decision-making process in managing 
pterygium patients, in which should not only consider 
surgical excision as the sole management. Hence, this study 
aims to evaluate the effects of different types of pterygium 
(type I, II and III) on changes in oculovisual function 
utilising BCVA and CS.
MATERIALS AND METHODS
Ninety three primary pterygium eyes from 93 patients were 
recruited in this study who visits a University eye-specialist 
in order to display a wide range of severity of pterygium 
patients. All participants in this study were selected based 
on specific criteria which includes established diagnosis 
of primary pterygium, both genders were included with 
age ranges from 20 to 70 years and free from any history 
of ocular trauma, ocular surgery, contact lens wear, and 
any ocular anterior segment disease other than pterygium 
which may affect vision (Azemin et al. 2014; Che Azemin 
et al. 2015, 2014; Mohd Radzi et al. 2017). Patients with 
significant ocular surface diseases such as recurrent 
pterygium, corneal opacity or irregularity due to diseases 
other than pterygium. A condition in obstruction of the 
central cornea by pterygium were also excluded. Diagnosis 
and classification of primary pterygium were performed 
by a single ocular surface expert (KMK). The study was 
conducted according to the recommendation of the tenets 
of the Declaration of Helsinki and approved by the 
International Islamic University Malaysia (IIUM) ethical 
research committee (IREC) (IIUM/310/G13/4/4-125). 
Written and informed consent was obtained from all 
participants before any procedures performed. 
Contrast sensitivity function (CS) and VA were 
measured using M&S Technologies Smart System II (SSII, 
Park Ridge, IL, USA). Both measurements were done by 
a single operator and performed on the same visit. Both 
BCVA and CS were measured using the M&S Smart System 
II (MSSS-II; M&S Technologies Inc. Niles, IL, US) in a 
dim room with a standardised luminance of 85 cd/m2 and 
colour temperature of 3300K as suggested by the 
manufacturer guideline (M&S Technologies Inc. 2011) 
and previous works (McClenaghan et al. 2007; Mohd Radzi 
et al. 2017). The usage of M&S Smart System II (MSSS-II; 
M&S Technologies Inc. Niles, IL, US) in measuring CS 
was found comparable with the gold-standard Pelli-Robson 
chart (Chandrakumar et al. 2013; Hilmi et al. 2018b). Then, 
all participants undergo pterygium excision using fibrin 
glue adhesive technique (Kurian et al. 2015), performed 
by a single surgeon (KMK). At third month post-surgical, 
all participants undergo similar procedures as in pre-
surgical session. The difference between pre and post-
surgical was taken as magnitude changes for each 
pterygium type. All data were then being exported to 
statistical software.
Statistical analyses were performed using IBM SPSS 
(Predictive analytics software) (Version 19, SPSS Inc., 
Chicago, IL, USA). Paired T-test was employed to evaluate 
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the difference between pre and post-surgical for both BCVA 
and CS for all pterygium types. One-way analysis of 
variance (ANOVA) was employed to evaluate if there is 
any significant difference between all pterygium groups 
for both BCVA and CS parameters. Bonferroni post-hoc 
analysis was employed to determine which pair was 
significant. A significance level of P < 0.05 was set as the 
confidence level.
RESULTS AND DISCUSSION
The analysis includes 93 participants, with 50.5% (n = 47) 
were men. Normality testing was evaluated using the ratio 
of skewness and kurtosis (George & Mallery 2010), with 
± 2.50 was taken as the normal distribution. Normality 
testing showed normal data distribution in all pterygium 
types. All participants were organised based on the 
pterygium types based on Tan’s classification of pterygium 
(Tan et al. 1997).
The mean of BCVA and CS for type I were 0.12 ± 0.05 
LogMAR and 6.40 ± 0.81%, respectively. Increasing trends 
were found with type II showed higher BCVA and CS 
compared to type I with 0.45 ± 0.22 LogMAR and 21.38 
± 9.29%, respectively. Based on our findings, type III was 
found the highest BCVA and CS values with 0.73 ± 0.22 
LogMAR and 44.58 ± 10.57%, respectively. Paired T-test 
results showed there was a significant difference in at least 
one pair of the group which indicates a significant 
difference in BCVA and CS values between pterygium 
groups (P < 0.05) in pre- and post-surgical sessions. 
Comparative analyses for pre- and post-surgical excision 
for BCVA and CS for each pterygium type were summarised 
in Table 1.
With regards to magnitude changes for each pterygium 
type, ANOVA results showed there is a significant 
difference in at least one pair of the group which indicates 
a significant difference in BCVA and CS values between 
pterygium groups (P < 0.001). Based on Bonferroni post-
hoc analysis, there was a significant difference between 
type I and II (0.02 ± 0.04), II and III (0.33 ± 0.20), and I 
and III (0.58 ± 0.21) for BCVA value (all P < 0.001). 
Likewise, for CS values, Bonferroni post-hoc analysis 
revealed a significant difference between type I and II (0.33 
± 0.76), II and III (15.19 ± 9.35), and I and III (37.87 ± 
9.99). Comparative analyses for magnitude changes in 
BCVA and CS for each pterygium type were summarised 
in Table 2.
Best-corrected visual acuity (BCVA) is a common 
visual parameter in assessing pterygium. However, it is 
rarely contrast sensitivity (CS) been discussed and 
addressed as part of an assessment for pterygium. Hence, 
this study aims to evaluate the effects of different types of 
pterygium (type I, II and III) on oculovisual function 
utilising two (2) visual performance parameters (BCVA 
and CS). This study employed an approximately similar 
number of samples for each pterygium types (type I; n = 
31, type II; n = 32, type III; n = 30) to evaluate the 
difference in BCVA and CS relative to pterygium types. 
TABLE 1. Comparative analyses between pre and post-surgical excision for BCVA and CS based on pterygium types (n = 93)
Variables
Type of pterygium (mean ± SD)
P-Value*Type Ia (n=30) Type IIb (n=32) Type IIIc (n=31)
Pre Post Pre Post Pre Post
BCVA 
(LogMAR) 0.12 ± 0.05 0.11 ± 0.03 0.45 ± 0.22 0.12 ± 0.04 0.73 ± 0.22 0.15 ± 0.06
ap = 0.023b 
p < 0.001c 
p < 0.001
CSF (%) 6.40 ± 0.81 6.07 ± 0.37 21.38 ± 9.29 6.19 ± 0.54 44.58 ± 10.57 6.71 ± 1.32
ap = 0.023b
p < 0.001c 
p < 0.001
* Paired t-test, significance level set at 0.05 (2-tailed); a P-value between pre and post-surgical for group type I;                                                                                            
b P-value between pre and post-surgical for group type II; c P-value between pre and post-surgical for group type III  
TABLE 2. Comparative analyses for magnitude changes in BCVA and CS for each pterygium type (n = 93)
Variables
Type of pterygium (mean ± SD) ANOVA
Type Ia (n=30) Type IIb (n=32) Type IIIc (n=31) P-value* Post-hoc#
BCVA (LogMAR) 0.02 ± 0.04 0.33 ± 0.20 0.58 ± 0.21 p < 0.001
ap < 0.001b 
p < 0.001c 
p < 0.001
CSF (%) 0.33 ± 0.76 15.19 ± 9.35 37.87 ± 9.99 p < 0.001
ap < 0.001b 
p < 0.001c 
p < 0.001
*Significance level set at 0.05 (2-tailed); # Based on Bonferroni correction post-hoc, significance level set at 0.05 (2-tailed); a P-value between type I and II; b P-value 
between type II and III; c P-value between type I and III  
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This study showed that the increase of pterygium types 
showed a decrease in both BCVA and CS values. 
The decrease in both BCVA and CS values indicate 
lower visual performance. Results showed type III 
pterygium induced most decrement in BCVA with 0.73 ± 
0.22 LogMAR compared to type II and I with 0.45 ± 0.22 
LogMAR and 0.12 ± 0.05 LogMAR, respectively. Based 
on our findings, it is postulated that fleshiness appearance 
in type III pterygium could be the cause of the reduction 
as the whitish appearance of pterygium which gives rise 
to obscured episcleral vessels could be due to the presence 
of fibrovascular tissue due to excessive proliferative 
disorders (Džunic et al. 2010; Reda et al. 2018; Ribatti et 
al. 2009). The excessive proliferative growth of pterygium 
could induce corneal compression which may also lead to 
the reduction in BCVA.
This study also found that CS values decreased 
incoherent with types of pterygium. Pterygium type III 
induced most reduction in contrast sensitivity with 44.58 
± 10.57% compared to type II and I with 21.38 ± 9.29% 
and 6.40 ± 0.81%, respectively. To the best of our 
knowledge, information on CS related to pterygium is 
scarce (Hilmi et al. 2018b; Oh & Wee 2010). However, it 
is suggested that a decrease in CS could be due to types of 
pterygium, which indirectly inducing scattering of light 
due to translucence corneal surface in the pterygium region. 
Although these findings look promising, it needs to be 
highlighted that both BCVA and CS only measures changes 
on the central cornea, approximately 5 mm centrally. The 
overall effect of pterygium progression is still unknown as 
the measurement could only cover the central and mid-
peripheral cornea. Hence, the effects of other morphology 
such as size, width and extension of pterygium would also 
be essential to be addressed.
Researchers has been looking at various pterygium 
morphology in deciphering the cause of visual degradation 
in pterygium, and the reason of why each pterygium effect 
is different from one to another. In the past decades, 
pterygium morphologies such as length, its total area and 
size were found significantly correlated in reduction in 
oculovisual function (Altan-Yaycioglu et al. 2013; 
Farhood & Kareem 2012; Gumus et al. 2011; Kheirkhah 
et al. 2012; Lin & Stern 1998; Muhammad-Salih & Sharif 
2008; Vives et al. 2013). However, clinical evidences 
showed that a large or longer pterygium does not always 
gave a significant impact on oculovisual function. 
Previous work (Muhammad-Salih & Sharif 2008) 
reported that pterygium total area of > 6.25 mm2 induced 
significant reduction in oculovisual function in form of 
corneal astigmatism of 2 D, as supported by recent studies 
(Altan-Yaycioglu et al. 2013; Vives et al. 2013). However, 
Avisar et al. (2000) and Lin and Stern (1998) reported 
contradictory findings with pterygium total area of >16% 
and > 45% induced significant corneal astigmatism of > 
1 D, respectively. On top of that, Lin and Stern (1998) 
also commented that pterygium total area < 45% of 
corneal radius were only weakly correlated (r = 0.180, P 
< 0.05) while total area of > 45% were highly correlated 
with reduction in oculovisual function in form of corneal 
astigmatism (r = 0.960, P < 0.001). 
With regards to pterygium length, several studies 
(Kampitak 2003; Muhammad-Salih & Sharif 2008) 
reported that the correlation between length of pterygium 
and induced reduction in oculovisual function in form of 
corneal astigmatism was found significant with ≥ 2 mm 
would induced ≥ 2 D. However, recent work (Farhood & 
Kareem 2012) reported contradict findings with ≥ 2 mm 
would induced ≥ 1 D. These evidences indicate that relying 
on length and size are inadequate to determine the impact 
of pterygium on changes in oculovisual function. These 
could be due to the characteristics of pterygium which does 
not abide to any specific shapes and length. An attempt 
was made (Mohd Radzi et al. 2019) recently to quantify 
both total area and length using image analysis. It was 
found that the combination of these two morphologies 
could predict approximately 32% changes in oculovisual 
function. However, it was noted that the fleshiness 
(translucence) of pterygium could be the possible key to 
solve the problem as different types of pterygium was found 
able to predict a large range of reduction in oculovisual 
function, as suggested in this study findings. This could 
explain the reason why previous studies findings (Altan-
Yaycioglu et al. 2013; Avisar et al. 2000; Farhood & 
Kareem 2012; Gumus et al. 2011; Kampitak 2003; 
Kheirkhah et al. 2012; Lin & Stern 1998; Muhammad-Salih 
& Sharif 2008; Vives et al. 2013) were varied from one to 
another. 
Previous work (Oh & Wee 2010) commented that 
pterygium progression induced reduction in oculovisual 
function could be due to two factors; BCVA and CS. 
However, direct comparison could not be made as the study 
did not adopt similar classification as in this current work. 
A recent work (Sandra et al. 2014) attempt to evaluate both 
BCVA and CS in different types of pterygium based on 
Tan’s classification of pterygium. Interestingly, the authors 
found that there was no significant difference between all 
three types of pterygium on changes in BCVA and CS, 
which contradict with the current work findings. This 
happen due to number of samples recruited in the previous 
work (Sandra et al. 2014) were mainly type I pterygium 
(atrophic), with very limited samples for type II 
(intermediate) and type III (fleshy). While this current work 
evaluates the changes in approximately similar number of 
samples for each type of pterygium type. Thus, comparison 
on changes on oculovisual function is well-presented in 
this current work.
Based on these evidences, recent studies had proposed 
the potential pterygium morphologies that could provide 
better insight on the impact of pterygium on oculovisual 
function. Potential pterygium morphologies were 
introduced which known as pterygium thickness (Hilmi et 
al. 2018c), redness (Mohd Radzi et al. 2017) and net 
pterygium total mass (NTPM) (Mohd Radzi et al. 2019). 
This approach aimed to combine all possible morphologies 
in order to have a comprehensive prediction on how 
pterygium affect oculovisual function. It was noted that by 
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adopting Tan’s classification of pterygium (Tan et al. 1997), 
better prediction can be made based on the pterygium types 
as the characteristics for each pterygium type are varies 
from one to another, and with different type of pterygium 
could have various morphological characteristics, it is now 
important for clinicians to note that types of pterygium 
need to be evaluated alongside with its morphological 
characteristics in order to have better view on managing 
pterygium patients.
CONCLUSION
Both BCVA and CS are important factors that can be used 
to differentiate the levels of reduction in oculovisual 
function based on pterygium types. Pterygium management 
should be based on pterygium types and levels of reduction 
in oculovisual function. 
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